Cargando…
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
Fibrotic diseases are characterized by net accumulation of extracellular matrix proteins in affected organs leading to their dysfunction and ultimate failure. Myofibroblasts have been identified as the cells responsible for the progression of the fibrotic process, and they originate from several sou...
Autores principales: | Pardali, Evangelia, Sanchez-Duffhues, Gonzalo, Gomez-Puerto, Maria Catalina, ten Dijke, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666838/ https://www.ncbi.nlm.nih.gov/pubmed/29039786 http://dx.doi.org/10.3390/ijms18102157 |
Ejemplares similares
-
TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020) -
TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors
por: Ma, Jin, et al.
Publicado: (2021) -
The therapeutic potential of targeting the endothelial-to-mesenchymal transition
por: Man, Shirley, et al.
Publicado: (2018) -
TGFβ Signaling and Cardiovascular Diseases
por: Pardali, Evangelia, et al.
Publicado: (2012) -
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)